繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

納斯達克(COLI:COLI)下跌0.1%

2022-07-06 14:31

Colicity Inc. (NASDAQ:COLI – Get Rating) shares traded down 0.1% during mid-day trading on Tuesday . The company traded as low as $9.79 and last traded at $9.79. 5,418 shares were traded during mid-day trading, a decline of 89% from the average session volume of 48,366 shares. The stock had previously closed at $9.80.

納斯達克股票代碼:COLI-GET Rating)股價周二午盤下跌0.1%。該公司股價低至9.79美元,最新報9.79美元。午盤成交量為5,418股,較48,366股的平均日成交量下降89%。該股此前收盤價為9.80美元。

The business has a fifty day moving average of $9.79 and a 200-day moving average of $9.76.

該業務的50日移動均線切入位在9.79美元,200日移動均線切入位在9.76美元。

Get
到達
Colicity
結腸病
alerts:
警報:

Several institutional investors and hedge funds have recently modified their holdings of COLI. Aristeia Capital LLC bought a new position in shares of Colicity in the 1st quarter worth $11,585,000. Silver Rock Financial LP bought a new position in Colicity during the 4th quarter valued at $6,818,000. Sculptor Capital LP lifted its stake in Colicity by 106.0% during the 1st quarter. Sculptor Capital LP now owns 1,134,636 shares of the company's stock valued at $11,085,000 after acquiring an additional 583,897 shares in the last quarter. P Schoenfeld Asset Management LP bought a new position in Colicity during the 1st quarter valued at $3,986,000. Finally, Saba Capital Management L.P. lifted its stake in Colicity by 200.2% during the 1st quarter. Saba Capital Management L.P. now owns 588,619 shares of the company's stock valued at $5,751,000 after acquiring an additional 392,553 shares in the last quarter. Institutional investors own 54.14% of the company's stock.

幾家機構投資者和對衝基金最近調整了對Coli的持股。Aristeia Capital LLC在第一季度購買了價值11,585,000美元的Colicity股票的新頭寸。Silver Rock Financial LP在第四季度購買了Colicity的新頭寸,價值6818,000美元。雕塑家Capital LP在第一季度增持了106.0%的Colicity股份。雕塑家Capital LP在上個季度增持了583,897股后,現在擁有1,134,636股該公司股票,價值11,085,000美元。P Schoenfeld Asset Management LP在第一季度購買了Colicity的一個新頭寸,價值3986,000美元。最后,薩巴資本管理公司在第一季度將其在Colicity的持股比例提高了200.2%。Saba Capital Management L.P.在上個季度增持了392,553股后,現在擁有588,619股該公司股票,價值5,751,000美元。機構投資者持有該公司54.14%的股份。

About Colicity
關於大腸埃希菌
(NASDAQ:COLI)
(納斯達克:大腸桿菌)

Colicity Inc does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on identifying a prospective target business in the technology, media, and telecommunications industries in the United States and other developed countries.

Colicity Inc.沒有重大業務。它側重於實現與一個或多個企業的合併、資本換股、資產收購、股票購買、重組或類似的企業合併。該公司打算將搜索重點放在確定美國和其他發達國家的技術、媒體和電信行業的潛在目標業務上。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on Colicity (COLI)
  • Vera Bradley Stock Getting Cheap
  • 3 Education Stocks to Enroll in This Summer
  • The Institutions Get Comfortable With The Lovesac Company
  • McDonald's Might Just Be The Best Recession Proof Stock
  • Basset Furniture Quietly Proves Its Value
  • 免費獲取StockNews.com關於大腸菌病的研究報告(Coli)
  • 維拉·布拉德利的股票越來越便宜
  • 3只教育類股將於今夏入圍
  • 這些機構對Lovesac公司感到滿意
  • 麥當勞可能就是最好的抗衰退股票
  • Basset家俱悄然證明其價值

Receive News & Ratings for Colicity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colicity and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Colicity Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Colicity和相關公司的最新新聞和分析師評級的每日簡要摘要。

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。